interleukin-2-like growth factor (Yeda)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameinterleukin-2-like growth factor (Yeda)
Drug Alias NameIL-2-like growth factorint2likf
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin-2 receptor agonistsGrowth factor receptors agonists
TargetsInterleukin-2 receptorGrowth factor receptors
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWeizmann Institute Of Science
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWeizmann Institute Of ScienceFarmitalia Carlo Erba Srl
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A